Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy (Q37632159)
Jump to navigation
Jump to search
scientific article published on 04 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy |
scientific article published on 04 February 2014 |
Statements
1 reference
Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy (English)
1 reference
D E Oppenheim
A Etuk
E Amofah
C Peña-Murillo
T Murray
L McLaughlin
B S Choi
S Allan
A Belousov
A Passioukov
C Gerdes
P Umaña
4 February 2014
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference